Search

Blogs

Tagged Content List
  • Blog Post: JDRF Annual Conference: Help Get Ready

    In June, JDRF’s Annual Conference will be held in Washington, D.C. and you can help us get ready for it – visit our call-to-action page and send a message of thanks to Members of Congress who supported the Special Diabetes Program (SDP) letter recently issued by the House and Senate Diabetes...
  • Blog Post: First Artificial Pancreas Outpatient Trial in the U.S. Gets FDA Approval

    I wanted to share with you the very exciting news that FDA recently approved the first clinical trial in the U.S. of an artificial pancreas system to be performed outside of a hospital! See the JDRF statement for more details . It’s great to see the research advancing and FDA helping to make it...
  • Blog Post: Post-Government Day Meeting Digest

    It has been a busy week here at JDRF Advocacy! On Monday and Tuesday, advocates were fervently fighting for research funding by meeting with Members of Congress on Capitol Hill as a part of JDRF's Government Day event. The attendees met with a total of 504 Member offices! Advocates who were unable...
  • Blog Post: FDA Artificial Pancreas Draft Guidance – What JDRF Thinks

    As you know, JDRF conducted an extensive advocacy campaign in 2011 which resulted in FDA release of draft artificial pancreas guidance in December. Since then, our team has completed a thorough analysis of the FDA draft, speaking with many experts. Overall, we still remain very encouraged by the guidance...
  • Blog Post: 150 to Go and A Special Piece from Rep. Jean Schmidt

    Advocates across the country are already working with renewed passion to get the remaining Promise meetings scheduled in 2012. As of this afternoon, 26 meetings have been scheduled during the month of January, bringing our grand total to 286. This means that we have met and surpassed yet another crucial...
  • Blog Post: After the Guidance – What Happens Now?

    Happy New Year! I know many of you have been following developments with the artificial pancreas guidance from FDA, so I wanted to give you an update about what’s been going on. After FDA released the artificial pancreas draft guidance document on December 1st our initial review was that the guidance...
  • Blog Post: A New Promise for the Special Diabetes Program

    2011 was an exciting year for JDRF Advocacy, especially with the Promise to Remember Me Campaign ! The year saw the completion of 260 meetings with Members of Congress, which we could not have done without advocates like you. However, we still have another 4 months left of the Campaign. The meeting total...
  • Blog Post: Would you talk to T1D?

    Last week, we told you that currently 85% of people with T1D are adults and this little piece of information generated lots of great feedback from you all. Many of the comments were hopeful and others, about the obstacles you face while beating T1D every day of your life. (Again, I want to thank you...
  • Blog Post: We're Back! Your New Years Promise Digest

    The holidays are over, so that means it is time to hit the ground running again for the Promise Campaign! We have 271 meetings, and still another week and a half left of recess. I am excited to see what our total will be for this month now that the craziness of the holiday season is done! We will be...
Page 1 of 34 (850 items) 12345»

ABOUT JUVENATION
Juvenation is a vibrant social network created especially for and by people with type 1 diabetes and their loved ones. More about Juvenation

Terms of Service | Privacy Policy

DONATION
Please consider making a donation to JDRF to support research toward better treatments and a cure for type 1 diabetes.

SUPPORT
For help on Juvenation you can view answers to common support questions or contact us.


JDRF is the worldwide leader for research to prevent, better treat, and ultimately cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. More about JDRF Juvenation is funded through an educational grant from Novo Nordisk through its Changing Diabetes© leadership initiative. More about Novo Nordisk